1. Home
  2. TCI vs NKTR Comparison

TCI vs NKTR Comparison

Compare TCI & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCI
  • NKTR
  • Stock Information
  • Founded
  • TCI 1983
  • NKTR 1990
  • Country
  • TCI United States
  • NKTR United States
  • Employees
  • TCI N/A
  • NKTR N/A
  • Industry
  • TCI Real Estate
  • NKTR Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCI Finance
  • NKTR Health Care
  • Exchange
  • TCI Nasdaq
  • NKTR Nasdaq
  • Market Cap
  • TCI 239.2M
  • NKTR 238.7M
  • IPO Year
  • TCI N/A
  • NKTR 1994
  • Fundamental
  • Price
  • TCI $27.52
  • NKTR $1.36
  • Analyst Decision
  • TCI
  • NKTR Buy
  • Analyst Count
  • TCI 0
  • NKTR 4
  • Target Price
  • TCI N/A
  • NKTR $2.50
  • AVG Volume (30 Days)
  • TCI 2.9K
  • NKTR 1.0M
  • Earning Date
  • TCI 11-07-2024
  • NKTR 11-05-2024
  • Dividend Yield
  • TCI N/A
  • NKTR N/A
  • EPS Growth
  • TCI N/A
  • NKTR N/A
  • EPS
  • TCI 0.69
  • NKTR N/A
  • Revenue
  • TCI $50,541,000.00
  • NKTR $93,157,000.00
  • Revenue This Year
  • TCI N/A
  • NKTR N/A
  • Revenue Next Year
  • TCI N/A
  • NKTR N/A
  • P/E Ratio
  • TCI $40.08
  • NKTR N/A
  • Revenue Growth
  • TCI N/A
  • NKTR 6.17
  • 52 Week Low
  • TCI $26.91
  • NKTR $0.41
  • 52 Week High
  • TCI $43.40
  • NKTR $1.93
  • Technical
  • Relative Strength Index (RSI)
  • TCI 41.66
  • NKTR 59.09
  • Support Level
  • TCI $27.38
  • NKTR $1.24
  • Resistance Level
  • TCI $28.36
  • NKTR $1.42
  • Average True Range (ATR)
  • TCI 0.57
  • NKTR 0.09
  • MACD
  • TCI -0.04
  • NKTR 0.01
  • Stochastic Oscillator
  • TCI 32.32
  • NKTR 80.65

About TCI Transcontinental Realty Investors Inc.

Transcontinental Realty Investors Inc is a fully integrated externally managed real estate company. It operates multifamily and commercial properties throughout the southern United States and also invests in mortgage notes receivable and in the land that is either held for appreciation or development. The company has two business segments: the acquisition, development, ownership, and management of multifamily properties which include the rental of apartments (Residential Segment) and other tenant services, including parking and storage space rental, and the acquisition, development, ownership, and management of commercial properties which are office properties(Commercial Segment). It includes the rental of office space and other tenant services, including parking and storage space rental.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

Share on Social Networks: